在帕金森病中使用血清胆酸概况和机器学习对认知障碍的风险进行分类
Tong Shen1, Can Cui2, Ruiqi Liu3
1Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu Province, China.
NPJ Parkinson's disease
|December 8, 2025
概括
帕金森病 (PD) 中胆酸 (BA) 变化与认知障碍 (CI) 有关. 在患有CI的PD患者中,明显的BA概况可能有助于早期检测认知能力下降.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 代谢学 代谢学 代谢学
背景情况:
- 认知障碍 (CI) 是帕金森病 (PD) 的常见早期非运动症状.
- 在PD中CI背后的生物化学机制尚不清楚.
- 胆酸 (BAs) 越来越多地与神经退行性过程有关.
研究的目的:
- 为了研究PD患者与没有认知障碍之间的血清BA概况的差异.
- 为了确定BA概况是否可以对帕金森病中的认知状态进行分类.
- 探索特定BA与PD认知功能之间的关系.
主要方法:
- 在363名参与者中使用超高性能液体染色学-并联质谱测量血清BA度 (63名对照组,154名具有正常认知能力的PD,146名具有CI的PD).
- 采用多变量统计分析和机器学习模型 (包括随机森林).
- 评估了BA水平和认知评分之间的相关性.
主要成果:
- 与正常认知患者相比,患有CI的PD患者显示出明显的血清BAA变化.
- 具体来说,在CI的PD中观察到高的脱氧胆酸和胆酸,以及降低的合BA.
- 脱氧胆酸水平与认知表现有很强的负相关性.
- 机器学习模型准确地区分了患有CI和没有CI的PD患者 (AUC高达0.90).
结论:
- 胆酸失调与帕金森病的认知障碍显著相关.
- 血清BA样本代表了早期识别PD中CI的潜在代谢生物标志物.
- 对BA代谢的进一步研究可能为PD相关认知衰退提供新的治疗点.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.9K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
8.2K
相关概念视频
Parkinson's Disease: Treatment
945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
